South African pharmaceutical executive Stephen Saad has suffered another setback as the market value of his stake in Aspen Pharmacare Holdings Ltd. continues to slide alongside the companys shares on the Johannesburg Stock Exchange.
Saad, the co-founder and chief executive of Aspen, Africas largest drugmaker, has seen more than 19 million erased from his stake over the past month. The decline adds to a string of losses that have weighed on investors, reflecting a difficult period for Aspen under Stephen Saad.
Stake value under pressure
